Pneumococcal Polysaccharide Vaccine
Market
Pneumococcal Polysaccharide Vaccine Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Pneumococcal Polysaccharide Vaccine Market Size and Growth
The global Pneumococcal Polysaccharide Vaccine market is expected to grow significantly due to rising awareness about the importance of vaccination. The market size is projected to reach USD XX million by 2025, driven by increasing government initiatives and overall healthcare expenditure. This report provides comprehensive insights into market trends and opportunities for key players.
Companies Covered
(Covid 19 Impact Covered)
◍ Merck & Co., Inc.
◍ Pfizer Inc.
◍ Glaxosmithkline Plc.
◍ Sanofi Pasteur
◍ China National Biotec Group
◍ Astellas Pharma Inc
◍ Serum Institute of India Pvt. Ltd
The competitive landscape of the Pneumococcal Polysaccharide Vaccine Market is dominated by companies like Merck & Co., Inc., Pfizer Inc., Glaxosmithkline Plc., Sanofi Pasteur, China National Biotec Group, Astellas Pharma Inc, and Serum Institute of India Pvt. Ltd. These companies play a significant role in developing, manufacturing, and distributing pneumococcal polysaccharide vaccines, thereby contributing to the growth of the market.
- Merck & Co., Inc.: $46.23 billion
- Pfizer Inc.: $51.75 billion - Glaxosmithkline Plc.: $35.35 billion
Request Sample Report
Market Segmentation
By Application
◍ Children (2-10 Age)
◍ Adult (10-64 Age)
◍ Geriatric (More Than 65 Age)
By Product
Single Dose Vial
Pre-Filled Syringe
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
